Veracyte, Inc.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Previously recorded as Allegro Diagnostics Corp. (to 2016)
Previously recorded as Decipher Biosciences, Inc. (to 2023)
14
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 7, 2027The maintenance fee for Compositions and Methods for Classifying Thyroid Nodule Disease (US 9,074,258) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.
- 1 fee due Mar 24, 2027The maintenance fee for Compositions and methods for classifying thyroid nodule disease (US 10,422,009) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
- 1 fee due Apr 15, 2027The maintenance fee for Methods and Compositions for Classification of Samples (US 10,446,272) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 2 fees due Jun 8 to 24, 2027 · next Jun 8
- 2 fees due Jul 7 to 16, 2027 · next Jul 7
- 1 fee due Nov 7, 2027The maintenance fee for Methods and systems for detecting usual interstitial pneumonia (US 11,976,329) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,865,452 | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 10,114,924 | Methods for Processing or Analyzing Sample of Thyroid Tissue In force · High confidence | In force | High confidence | |
| US 10,236,078 | Methods for Processing or Analyzing a Sample of Thyroid Tissue In force · High confidence | In force | High confidence | |
| US 10,672,504 | Algorithms for Disease Diagnostics In force · High confidence | In force | High confidence | |
| US 10,731,223 | Algorithms for Disease Diagnostics In force · High confidence | In force | High confidence | |
| US 12,305,238 | Methods for Treatment of Thyroid Cancer In force · Low confidence | In force | Low confidence | |
| US 9,714,452 | Compositions and Methods for Classifying Thyroid Nodule Disease In force · High confidence | In force | High confidence | |
| US 10,422,009 | Compositions and methods for classifying thyroid nodule disease In force · From the USPTO record | In force | From the USPTO record | |
| US 9,206,482 | Systems and Methods for Expression-Based Classification of Thyroid Tissue In force · High confidence | In force | High confidence | |
| US 9,617,604 | Systems and Methods for Expression-Based Classification of Thyroid Tissue In force · High confidence | In force | High confidence |
Also on record, not counted in the 30: 4 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
12 pending · 21 abandoned · 16 no status recorded